Filter
461
Text search:
V.
Patel
Featured
Recommendations
40
New Publications
61
Language
Document type
No document type
247
Studies & Reports
100
Guidelines
71
Fact sheets
13
Manuals
11
Strategic & Response Plan
11
Training Material
5
Situation Updates
2
Resource Platforms
1
Countries / Regions
India
32
Global
20
Latin America and the Carribbean
15
Russia
12
Brazil
11
Western and Central Europe
11
Eastern Europe
9
South Africa
7
Mozambique
7
Kenya
6
Africa
6
Germany
5
Ukraine
4
Angola
4
Nigeria
3
Guinea-Bissau
3
Ethiopia
3
Uganda
3
Syria
3
Indonesia
3
Middle East and North Africa
3
Liberia
2
Ghana
2
Zimbabwe
2
Philippines
2
Nepal
2
South Sudan
2
Peru
2
Colombia
2
Ecuador
2
Botswana
2
Guatemala
2
Tajikistan
2
Spain
2
Sierra Leone
1
Pakistan
1
Iraq
1
Egypt
1
Tanzania
1
Thailand
1
Rwanda
1
Bangladesh
1
Malawi
1
Sudan
1
Central African Republic
1
Argentina
1
Dominican Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Burundi
1
Honduras
1
El Salvador
1
Bolivia
1
Mexico
1
Nicaragua
1
Myanmar / Burma
1
Sri Lanka
1
Chile
1
Yemen
1
Eastern Europe and Central Asia
1
Other region
1
Asia
1
Venezuela
1
Armenia
1
Southern Africa
1
Canada
1
Georgia
1
Belgium
1
United Kingdom
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
34
Public Health
29
Women & Child Health
15
Key Resources
8
Pharmacy & Technologies
2
Capacity Building
1
Toolboxes
Mental Health
148
COVID-19
71
HIV
44
NCDs
21
TB
13
AMR
13
Planetary Health
13
Disability
12
Health Financing Toolbox
11
Caregiver
9
NTDs
8
Conflict
7
Rapid Response
7
Refugee
7
Ebola
5
Natural Hazards
5
Global Health Education
5
Pharmacy
4
Zika
2
Cholera
1
Polio
1
Specific Hazards
1
Social Ethics
1
SADJ August 2016, Vol 71 no 7 p314 - p318
Clinical Review
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
Accessed Febr. 6, 2020
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar
...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a
...
Stand 2.10.2020
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden hacerlas más susceptibles a las infecciones respiratorias virales, incluido COVID-19. Varios estudios revelaron que las mujeres embarazadas con diferentes enfermedades resp
...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use in clinical laboratories and doesnot cover technical
...
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally.
...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t
...
Scientific brief
8 April 2020
Considerations for implementing and adjusting public health and social measures in the context of COVID-19
recommended
interim guidance, 14 June 2021
This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases
...
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud
...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri
...
Infection prevention and control (IPC) practices are of critical importance in protecting the function of healthcare services at all levels and mitigating the impact on vulnerable populations. Although the management of possible COVID-19 cases is usually guided by national policies for specific heal
...
